Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.

Akihiro Doi,Masayuki Ota,Masumichi Saito,Shutoku Matsuyama

Emerging infectious diseases（2024）

引用 0|浏览0

暂无评分

摘要

Using the GISAID EpiCoV database, we identified 256 COVID-19 patients in Japan during March 31-December 31, 2023, who had mutations in the SARS-CoV-2 nonstructural protein 5 conferring ensitrelvir resistance. Ongoing genomic surveillance is required to monitor emergence of SARS-CoV-2 mutations that are resistant to anticoronaviral drugs.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要